BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/17/2017 8:32:00 AM | Browse: 292 | Download: 549
Publication Name World Journal of Hepatology
Manuscript ID 31379
Country of Manuscript Source United States
2016-11-14 09:29
Peer-Review Started
2016-11-15 10:52
To Make the First Decision
2016-12-01 09:07
Return for Revision
2016-12-01 11:03
2016-12-15 07:48
Second Decision
2017-01-04 16:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-01-14 14:14
Articles in Press
2017-01-14 14:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-02-13 17:39
Publish the Manuscript Online
2017-02-17 08:32
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Observational Study
Article Title Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
Manuscript Source Unsolicited Manuscript
All Author List Zeeshan Ahmad Wani, Sonmoon Mohapatra, Afaq Ahmad Khan, Ashutosh Mohapatra and Ghulam Nabi Yatoo
Funding Agency and Grant Number
Correspondence To Sonmoon Mohapatra, MD, Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School/Saint Peters University Hospital, 254 Easton Ave, New Brunswick, NJ 08901, United States. sonmoon0mohapatra@gmail.com
Keywords Simvastatin; Cirrhosis; Carvedilol; Liver cirrhosis; Portal hypertension; Hepatocellular carcinoma
Core Tip There is no pharmacological option available for treatment of carvedilol nonresponders in patients with portal hypertension. Addition of simvastatin could be an important pharmacological rescue therapy for carvedilol nonresponders. This study showed that addition of simvastatin to carvedilol non responders can increase overall response to around 80%, which is one of the best possible pharmacologically produced chronic response and it opens a new strategy for portal hypertension treatment.
Publish Date 2017-02-17 08:32
Citation Wani ZA, Mohapatra S, Khan AA, Mohapatra A, Yatoo GN. Addition of simvastatin to carvedilol non responders: A new rescue therapy for treatment of portal hypertension. World J Hepatol 2017; 9(5): 270-277
Url http://www.wjgnet.com/1948-5182/full/v9/i5/270.htm
DOI http://dx.doi.org/10.4254/wjh.v9.i5.270
Full Article (PDF) WJH-9-270.pdf
Full Article (Word) WJH-9-270.doc
Revised Manuscript 31379-Review.docx
Peer-review Report 31379-Peer-review(s).pdf
Answering Reviewers 31379-Answering reviewers.pdf
Scientific Misconduct Check 31379-Scientific misconduct check.pdf
Scientific Editor Work List 31379-Scientific editor work list.pdf
Audio Core Tip 31379-Audio core tip.mp3
Biostatistics Review Certificate 31379-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 31379-Conflict-of-interest statement.pdf
Copyright License Agreement 31379-Copyright assignment.pdf
Data Sharing Statement 31379-Data sharing statement.pdf
Institutional Review Board Approval Form or Document 31379-Institutional review board statement.pdf
Scientific Research Process 31379-Scientific research process.pdf